Publication | Open Access

Optimization and structure–activity relationships of a series of potent inhibitors of methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase as novel antimicrobial agents

Antimicrobial Drug DiscoveryBiochemistryAntibioticsMedicinePyruvate KinaseAntibacterial AgentAntimicrobial TherapyAntimicrobial ChemotherapyStructure–activity RelationshipsPotent InhibitorsAntimicrobial CompoundPharmacologyAntimicrobial ResistanceDrug DiscoveryDrug Resistance